Myositis/myasthenia gravis caused by immune checkpoint inhibition: A report of two cases and a brief review of the literature.
Elavia Z, Jimenez V, Lockhart R, Muha A, Kazamel M.
Med Int (Lond). 2024 Dec 3;5(1):11. doi: 10.3892/mi.2024.210. eCollection 2025 Jan-Feb.
Pembrolizumab for Patients With Refractory or Relapsed Thymic Epithelial Tumor: An Open-Label Phase II Trial.
Cho J, Kim HS, Ku BM, Choi YL, Cristescu R, Han J, Sun JM, Lee SH, Ahn JS, Park K, Ahn MJ.
J Clin Oncol. 2019 Aug 20;37(24):2162-2170. doi: 10.1200/JCO.2017.77.3184. Epub 2018 Jun 15.
A new mitochondria-related disease showing myopathy with episodic hyper-creatine kinase-emia.
Okamoto Y, Higuchi I, Sakiyama Y, Tokunaga S, Watanabe O, Arimura K, Nakagawa M, Takashima H.
Ann Neurol. 2011 Sep;70(3):486-92. doi: 10.1002/ana.22498.
Concomitant dermatomyositis and myasthenia gravis presenting with respiratory insufficiency.
van de Warrenburg BP, Hengstman GJ, Vos PE, Boerman RH, ter Laak HJ, van Engelen BG.
Muscle Nerve. 2002 Feb;25(2):293-6. doi: 10.1002/mus.10022.
